Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.
HealthIT Analytics cited 2 studies from The American Journal of Managed Care this week. Jennifer Bresnick covered the study from the May 2016 issue, “Implementing a Hybrid Approach to Select Patients for Care Management: Variations Across Practices,” led by Christine Vogeli, PhD. As Bresnick writes, practices differ in how they select high-risk patients for care management programs, but most focus on older, sicker patients from the lower end of the socioeconomic scale.
An April 2015 study, “Persistent High Utilization in a Privately Insured Population,” led by Wenke Hwang, PhD, was cited in Jacqueline Belliveau’s article on efforts by Blue Cross Blue Shield of Illinois to launch an oncology medical home to improve care coordination. The Hwang study discussed the value of patient-centered care models in light of findings that chronic disease patients cost 17 times more than other patients.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More